Financing type: brokered private placement
Gross proceeds: $27,145,496.70
Offering: 4,308,809 listed shares with 75,404,166 warrants
Offering price: $6.30 per listed share
Warrant exercise terms: Following the company's March 6, 2026, 35-old-for-one new consolidation, 35 warrants are exercisable into one listed share at $10.50 per listed share for a three-year period. The total number of listed shares issuable upon exercise of the warrants is 2,154,404 listed shares.
Commissions in securities: 9,039,500 warrants
Commission terms:
Following the consolidation, 35 non-transferable warrants are exercisable into one listed share at an exercise price of $6.30 per listed share for a two-year period. The total number of listed shares issuable upon exercise of the non-transferable warrants is 258,272 listed shares.
Disclosure:
refer to the company's news release(s) dated Feb. 9, 2026, Feb. 13, 2026, March 5, 2026, March 6, 2026, March 10, 2026, and March 16, 2026
Additional information:
please refer to the TSX-V's bulletin dated March 4, 2026, for more information regarding the consolidation
© 2026 Canjex Publishing Ltd. All rights reserved.